Reciprocal inhibition of PIN1 and APC/CCDH1 controls timely G1/S transition and creates therapeutic vulnerabilityShizhong Ke(Beth Israel Deaconess Medical Center), Kun Ping Lu(Translational Therapeutics (United States))Research SquareJanuary 19, 202310.21203/rs.3.rs-2447544/v1Cited by 3SaveCiteExport RISWatch citationsRelated PapersChemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways|Scientific Reports|2017|53Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma|Oncotarget|2017|38